In her statement associated with her testimony to U.S. Congressional Committee on Oversight and Government Reform's Subcommittee on Energy Policy, Health Care, and Entitlements, Janet Woodcock cited 2 ISPE studies – survey conducted by ISPE UK Affiliate's Process Analytical Technology (PAT) Community of Practice, and Drug Shortages Survey report – to advocate use of Quality by Design (QbD) to enhance development capability and reduce manufacturing costs while ensuring quality drug ...This story is related to the following:Trade Associations